MSC IV Therapy
Systemic MSC infusion | Anti-inflammatory, tissue repair, systemic rejuvenation
About This Treatment
MSC IV therapy injects cultured mesenchymal stem cells systemically via IV—cutting-edge whole-body anti-aging. Traditional MSC transplant was localized (skin), but IV circulates MSCs throughout body via bloodstream for systemic rejuvenation.
MSCs automatically home to systemic inflammation sites, secreting anti-inflammatory factors (IL-10, TGF-β). Chronic inflammation reduces, suppressing age-associated systemic aging. Beyond skin, vascular, organ, and brain function rejuvenation expected—integrated anti-aging gaining attention.
Mechanism of Action
MSC IV infusion circulates high-concentration MSCs systemically. MSCs home to chronic inflammation sites throughout body (vascular endothelium, adipose tissue). Secrete anti-inflammatory cytokines (IL-10, TGF-β, HGF). Systemic inflammation reduces, suppressing excessive NF-κB pathway activation. Simultaneously, tissue repair factors produced, vascular endothelial function improves. Systemic blood flow improves, organ oxygen delivery increases. Whole-body regeneration capacity—including skin—improves.
Indications
Expected Results
Post-MSC IV therapy, inflammation markers (CRP, IL-6) dramatically decrease. Systemic fatigue reduces at 1-2 months. Skin texture improves, firmness increases at 2-3 months. Some patients show vascular age reversal, normalized blood pressure. Systemic rejuvenation felt at 6 months.
Clinical Evidence
Risks & Side Effects
Culture/infusion infection risk. Post-infusion transient fever, fatigue. Rare embolism (vascular occlusion) risk. Virus-negative product prerequisite. Caution in autoimmune disease patients.
Interested in this treatment?
Start with an AI skin analysis to check your current skin condition